<p>Bleomycin sulfate should be considered a palliative treatment. It has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents:<br />
<br />
<strong>Squamous Cell Carcinoma</strong>: Head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. The response to Bleomycin sulfate is poorer in patients with previously irradiated head and neck cancer.<br />
<br />
<strong>Lymphomas</strong>: Hodgkin&rsquo;s disease, non-Hodgkin&rsquo;s lymphoma.<br />
<br />
<strong>Testicular Carcinoma</strong>: Embryonal cell, choriocarcinoma, and teratocarcinoma. Bleomycin sulfate has also been shown to be useful in the management of Malignant Pleural Effusion</p>